Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
- PMID: 31221253
- PMCID: PMC10656059
- DOI: 10.1016/j.jacc.2019.04.022
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Abstract
Background: National guidelines recommend that systolic blood pressure (SBP) in patients with heart failure with reduced ejection fraction (HFrEF) and hypertension be maintained below 130 mm Hg.
Objectives: This study sought to determine associations of SBP <130 mm Hg with outcomes in patients with HFrEF.
Methods: Of the 25,345 patients in the Medicare-linked OPTIMIZE-HF registry, 10,535 had an ejection fraction (EF) ≤40%. Of these, 5,615 had stable SBP (≤20 mm Hg admission to discharge variation), and 3,805 (68%) had a discharge SBP <130 mm Hg. Propensity scores for SBP <130 mm Hg, estimated for each of the 5,615 patients, were used to assemble a matched cohort of 1,189 pairs of patients with SBP <130 versus ≥130 mm Hg, balanced on 58 baseline characteristics (mean age 76 years; mean EF 28%, 45% women, 13% African American). This process was repeated in 3,946 patients, after excluding 1,669 patients (30% of 5,615) with a discharge SBP <110 mm Hg and assembled a second matched balanced cohort of 1,099 pairs of patients with SBP 110 to 129 mm Hg versus ≥130 mm Hg.
Results: Thirty-day all-cause mortality occurred in 7% and 4% of matched patients with SBP <130 mm Hg versus ≥130 mm Hg, respectively (hazard ratio [HR]: 1.76; 95% confidence interval [CI]: 1.24 to 2.48; p = 0.001). HRs (95% CIs) for all-cause mortality, all-cause readmission, and HF readmission at 1 year, associated with SBP <130 mm Hg, were 1.32 (1.15 to 1.53; p < 0.001), 1.11 (1.01 to 1.23; p = 0.030), and 1.24 (1.09 to 1.42; p = 0.001), respectively. HRs (95% CIs) for 30-day and 1-year all-cause mortality associated with SBP 110 to 129 mm Hg (vs. ≥130 mm Hg) were 1.50 (1.03 to 2.19; p = 0.035), and 1.19 (1.02 to 1.39; p = 0.029), respectively.
Conclusions: Among hospitalized older patients with HFrEF, SBP <130 mm Hg is associated with poor outcomes. This association persisted when the analyses were repeated after excluding patients with SBP <110 mm Hg. There is an urgent need for randomized controlled trials to evaluate optimal SBP reduction goals in patients with HFrEF.
Keywords: heart failure; outcomes; systolic blood pressure.
Published by Elsevier Inc.
Conflict of interest statement
Figures
Comment in
-
Heart Failure Management Under Pressure.J Am Coll Cardiol. 2019 Jun 25;73(24):3064-3066. doi: 10.1016/j.jacc.2019.05.001. J Am Coll Cardiol. 2019. PMID: 31221254 No abstract available.
Similar articles
-
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.JAMA Cardiol. 2018 Apr 1;3(4):288-297. doi: 10.1001/jamacardio.2017.5365. JAMA Cardiol. 2018. PMID: 29450487 Free PMC article.
-
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.Am J Med. 2021 Apr;134(4):e252-e263. doi: 10.1016/j.amjmed.2020.08.030. Epub 2020 Sep 30. Am J Med. 2021. PMID: 33010225 Free PMC article.
-
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022. J Am Coll Cardiol. 2017. PMID: 28982499 Free PMC article.
-
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064. J Am Coll Cardiol. 2019. PMID: 31370952 Free PMC article.
-
Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.Am Heart J. 2013 Feb;165(2):216-25. doi: 10.1016/j.ahj.2012.11.004. Epub 2012 Dec 29. Am Heart J. 2013. PMID: 23351825 Clinical Trial.
Cited by
-
Clinical Characteristics and Outcomes of Dilated Cardiomyopathy in Chinese Children: A Single-Center Retrospective Study.Children (Basel). 2024 Aug 15;11(8):992. doi: 10.3390/children11080992. Children (Basel). 2024. PMID: 39201927 Free PMC article.
-
Value of the triglyceride-glucose index and related parameters in heart failure patients.Front Cardiovasc Med. 2024 Jul 18;11:1397907. doi: 10.3389/fcvm.2024.1397907. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39091358 Free PMC article. Review.
-
Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record.ESC Heart Fail. 2024 Oct;11(5):3155-3166. doi: 10.1002/ehf2.14787. Epub 2024 Jun 14. ESC Heart Fail. 2024. PMID: 38873749 Free PMC article.
-
Blood pressure and heart failure: focused on treatment.Clin Hypertens. 2024 Jun 1;30(1):15. doi: 10.1186/s40885-024-00271-y. Clin Hypertens. 2024. PMID: 38822445 Free PMC article. Review.
-
Correlation between systolic blood pressure and mortality in heart failure patients with hypertension.J Hypertens. 2024 Jun 1;42(6):1048-1056. doi: 10.1097/HJH.0000000000003693. Epub 2024 Feb 21. J Hypertens. 2024. PMID: 38406922 Free PMC article.
References
-
- Yancy CW, Jessup M, Bozkurt B et al.. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2017;70:776–803. - PubMed
-
- Meredith PA, Ostergren J, Anand I et al.. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol 2008;52:2000–7. - PubMed
-
- Fonarow GC, Abraham WT, Albert NM et al.. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 2004;148:43–51. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
